Policy

First Opinion By Jonathan Doh

Make drug companies partners — not adversaries — to expand global Covid-19 vaccine access

Opinions+ By John Freedman

The many benefits of expanding the reach of state all-payer claims databases

Health Tech By Andrew Joseph

Former Google CEO Schmidt says AI ‘will have its biggest impact’ in health care

Hospitals By Rachel Cohrs

HHS plans to open up billions in hospital Covid-19 grants in coming weeks

Health By Alicia Diaz

Door knocking works to get information to immigrant communities. Why aren’t more places using it for Covid-19?

Politics By Nicholas Florko and Rachel Cohrs

Worried drug pricing reform might be left behind, Democrat pushes Biden to make clear his support

Exclusive By Nicholas Florko

Biden officials met privately with 3M, AmerisourceBergen, PhRMA, and more to debate shoring up the national stockpile

Opinions+ By Patrick McLaughlin and Tyler Richards

The FDA should embrace remote and automated drug inspection technology

Politics By Rachel Cohrs

The lobbying juggernaut the American Hospital Association is losing its top advocate at a critical moment for the industry

Politics By Nicholas Florko

Hints emerge about a key Senate committee’s plans for health care

First Opinion By Ethan Dmitrovsky

Rethinking triage in an era of vaccine nationalism

First Opinion Podcast By Patrick Skerrett

Listen: Two addiction specialists debunk the myth of ‘excited delirium’ used in police encounters

Politics By Nicholas Florko

PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform

Opinions+ By Pierre Bourdage

Three steps toward creating a functioning U.S. biosimilars market

First Opinion By Michael Carney

Make it easier for employers to help get America vaccinated

Politics By Lev Facher

Inside the White House’s push for a new, $6.5 billion agency aimed at curing cancer

Politics By Rachel Cohrs

Biden pushes Congress to boost public health, pandemic preparedness funding

First Opinion By Lubab al-Quraishi

Foreign-trained doctors like me were asked to help fight Covid-19. Now we’re being tossed aside

First Opinion Podcast By Patrick Skerrett

Listen: Antibiotic experts on the threat of antimicrobial resistant superbugs

First Opinion By Dinesh Thakur

India shouldn’t insist on ‘bridging trials’ in the middle of a pandemic

Politics By Rachel Cohrs

There’s no point person in Biden’s HHS for its $187 billion Covid-19 fund for health care providers

First Opinion By Ge Bai and David A. Hyman

Tax exemptions for nonprofit hospitals: It’s time taxpayers get their money’s worth

First Opinion By Alvin E. Roth and Greg Segal

Reforming and improving organ transplant systems will save lives, taxpayer dollars

Pill world map public-private partnership

First Opinion By Julia Barnes-Weise and Kendall Hoyt

MAPGuide: A tool to help improve health-related public-private partnership agreements

First Opinion By Brian Spisak

Most Read

‘Authorization’ status is a red herring when it comes to mandating Covid-19 vaccination

Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients

FDA to require strong warnings about combining pain pills with anxiety medication

Top Senate Democrat heads back to drawing board on drug pricing

The Trump administration quietly spent billions in hospital funds on Operation Warp Speed

Do public health officials need to be political activists? A fight over an HIV crisis renews the question

9 ways Covid-19 may forever upend the U.S. health care industry

FTC’s challenge to Illumina’s vertical merger with Grail is all wrong

All Coverage

Make drug companies partners — not adversaries — to expand global Covid-19 vaccine access

The many benefits of expanding the reach of state all-payer claims databases

Former Google CEO Schmidt says AI ‘will have its biggest impact’ in health care

HHS plans to open up billions in hospital Covid-19 grants in coming weeks

Door knocking works to get information to immigrant communities. Why aren’t more places using it for Covid-19?

Worried drug pricing reform might be left behind, Democrat pushes Biden to make clear his support

Biden officials met privately with 3M, AmerisourceBergen, PhRMA, and more to debate shoring up the national stockpile

The FDA should embrace remote and automated drug inspection technology

The lobbying juggernaut the American Hospital Association is losing its top advocate at a critical moment for the industry

Hints emerge about a key Senate committee’s plans for health care

Rethinking triage in an era of vaccine nationalism

Listen: Two addiction specialists debunk the myth of ‘excited delirium’ used in police encounters

PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform

Three steps toward creating a functioning U.S. biosimilars market

Make it easier for employers to help get America vaccinated

Inside the White House’s push for a new, $6.5 billion agency aimed at curing cancer

Biden pushes Congress to boost public health, pandemic preparedness funding

Foreign-trained doctors like me were asked to help fight Covid-19. Now we’re being tossed aside

Listen: Antibiotic experts on the threat of antimicrobial resistant superbugs

India shouldn’t insist on ‘bridging trials’ in the middle of a pandemic

There’s no point person in Biden’s HHS for its $187 billion Covid-19 fund for health care providers

Tax exemptions for nonprofit hospitals: It’s time taxpayers get their money’s worth

Reforming and improving organ transplant systems will save lives, taxpayer dollars

MAPGuide: A tool to help improve health-related public-private partnership agreements

Vaccination certificates won’t end lockdown. Prosocial approaches will

Most Read

All Coverage